?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
October 6, 2020
signalgroup
Biosimilars Could Generate $100 Billion in Savings Over Next Five Years, New Report Finds
News
September 21, 2020
signalgroup
U.S. Taxpayers and the Health Care System At-Large Have Lost out on Nearly $20 Billion in Savings Since 2018
News
September 10, 2020
signalgroup
The Biosimilars Forum Filed Comment on FDA’s Notice Detailing the Impact of Disclosure Statements in Biosimilar Promotional Materials
News
July 31, 2020
signalgroup
ICYMI: Experts Detail How Shared Savings Model for Biosimilars Could Provide Savings for Seniors, Patients and Medicare
News
July 31, 2020
signalgroup
MedPac: Top 10 Most Expensive Medicare Part B Drugs are Originator Biologics
News
July 24, 2020
signalgroup
Trump Administration’s Drug Plan Must Include Biosimilars to Lower Costs for Seniors and Medicare
News
July 14, 2020
signalgroup
ICYMI: House Appropriators Encourage CMS to Support Biosimilars; Experts Point to Biosimilars to Help Lower Drug Costs, Call on Congress and Administration to Act
News
July 1, 2020
signalgroup
The Biosimilars Forum Applauds Senators Cornyn and Bennet’s Introduction of Legislation to Lower Health Costs by Supporting Biosimilars
News
June 22, 2020
signalgroup
The Biosimilars Forum To Provide Comment at FDA’s Annual Meeting on the Biosimilar User Fee Program
News
May 28, 2020
signalgroup
Bringing Down Federal Spending: A Biosimilars Shared Savings Model To Lower Health Care Costs
Prev page
07
08
09
10
11
Next page